Literature DB >> 23470221

Fluorescent substrates for flow cytometric evaluation of efflux inhibition in ABCB1, ABCC1, and ABCG2 transporters.

J Jacob Strouse1, Irena Ivnitski-Steele, Anna Waller, Susan M Young, Dominique Perez, Annette M Evangelisti, Oleg Ursu, Cristian G Bologa, Mark B Carter, Virginia M Salas, George Tegos, Richard S Larson, Tudor I Oprea, Bruce S Edwards, Larry A Sklar.   

Abstract

ATP binding cassette (ABC) transmembrane efflux pumps such as P-glycoprotein (ABCB1), multidrug resistance protein 1 (ABCC1), and breast cancer resistance protein (ABCG2) play an important role in anticancer drug resistance. A large number of structurally and functionally diverse compounds act as substrates or modulators of these pumps. In vitro assessment of the affinity of drug candidates for multidrug resistance proteins is central to predict in vivo pharmacokinetics and drug-drug interactions. The objective of this study was to identify and characterize new substrates for these transporters. As part of a collaborative project with Life Technologies, 102 fluorescent probes were investigated in a flow cytometric screen of ABC transporters. The primary screen compared substrate efflux activity in parental cell lines with their corresponding highly expressing resistant counterparts. The fluorescent compound library included a range of excitation/emission profiles and required dual laser excitation as well as multiple fluorescence detection channels. A total of 31 substrates with active efflux in one or more pumps and practical fluorescence response ranges were identified and tested for interaction with eight known inhibitors. This screening approach provides an efficient tool for identification and characterization of new fluorescent substrates for ABCB1, ABCC1, and ABCG2.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23470221      PMCID: PMC3785545          DOI: 10.1016/j.ab.2013.02.018

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  44 in total

1.  Multidrug resistance: can new drugs help chemotherapy score against cancer?

Authors:  Bruce Goldman
Journal:  J Natl Cancer Inst       Date:  2003-02-19       Impact factor: 13.506

2.  Reciprocal correlation between expression of P-glycoprotein and accumulation of rhodamine 123 in human tumors.

Authors:  T Efferth; H Löhrke; M Volm
Journal:  Anticancer Res       Date:  1989 Nov-Dec       Impact factor: 2.480

3.  High-throughput flow cytometry: validation in microvolume bioassays.

Authors:  Sergio Ramirez; Charity T Aiken; Brett Andrzejewski; Larry A Sklar; Bruce S Edwards
Journal:  Cytometry A       Date:  2003-05       Impact factor: 4.355

4.  Dexniguldipine-HCl is a potent allosteric inhibitor of [3H]vinblastine binding to P-glycoprotein of CCRF ADR 5000 cells.

Authors:  J Malkhandi; D R Ferry; R Boer; V Gekeler; W Ise; D J Kerr
Journal:  Eur J Pharmacol       Date:  1994-12-15       Impact factor: 4.432

5.  Drug-drug interaction mediated by inhibition and induction of P-glycoprotein.

Authors:  Jiunn H Lin
Journal:  Adv Drug Deliv Rev       Date:  2003-01-21       Impact factor: 15.470

6.  Pheophorbide a is a specific probe for ABCG2 function and inhibition.

Authors:  Robert W Robey; Kenneth Steadman; Orsolya Polgar; Kuniaki Morisaki; Margaret Blayney; Prakash Mistry; Susan E Bates
Journal:  Cancer Res       Date:  2004-02-15       Impact factor: 12.701

7.  Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients.

Authors:  R F Ozols; R E Cunnion; R W Klecker; T C Hamilton; Y Ostchega; J E Parrillo; R C Young
Journal:  J Clin Oncol       Date:  1987-04       Impact factor: 44.544

8.  A functional study on polymorphism of the ATP-binding cassette transporter ABCG2: critical role of arginine-482 in methotrexate transport.

Authors:  Hideyuki Mitomo; Ryo Kato; Akiko Ito; Shiho Kasamatsu; Yoji Ikegami; Isao Kii; Akira Kudo; Eiry Kobatake; Yasuhiro Sumino; Toshihisa Ishikawa
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

9.  Reversal of breast cancer resistance protein (BCRP/ABCG2)-mediated drug resistance by novobiocin, a coumermycin antibiotic.

Authors:  Ken Shiozawa; Mikio Oka; Hiroshi Soda; Megumi Yoshikawa; Yoji Ikegami; Junji Tsurutani; Katsumi Nakatomi; Yoichi Nakamura; Seiji Doi; Takeshi Kitazaki; Yohei Mizuta; Kunihiko Murase; Hisahiro Yoshida; Douglas D Ross; Shigeru Kohno
Journal:  Int J Cancer       Date:  2004-01-01       Impact factor: 7.396

10.  Bodipy-FL-verapamil: a fluorescent probe for the study of multidrug resistance proteins.

Authors:  Anna Rosati; Luigi Candussio; Enrico Crivellato; Fiora Bartoli Klugmann; Tullio Giraldi; Daniela Damiani; Angela Michelutti; Giuliana Decorti
Journal:  Cell Oncol       Date:  2004       Impact factor: 6.730

View more
  29 in total

Review 1.  Transport in technicolor: mapping ATP-binding cassette transporters in sea urchin embryos.

Authors:  Tufan Gökirmak; Lauren E Shipp; Joseph P Campanale; Sascha C T Nicklisch; Amro Hamdoun
Journal:  Mol Reprod Dev       Date:  2014-08-22       Impact factor: 2.609

2.  Multi-Drug Resistance ABC Transporter Inhibition Enhances Murine Ventral Prostate Stem/Progenitor Cell Differentiation.

Authors:  Mugdha D Samant; Courtney M Jackson; Carina L Felix; Anthony J Jones; David W Goodrich; Barbara A Foster; Wendy J Huss
Journal:  Stem Cells Dev       Date:  2015-02-25       Impact factor: 3.272

Review 3.  Disruption of small molecule transporter systems by Transporter-Interfering Chemicals (TICs).

Authors:  Sascha C T Nicklisch; Amro Hamdoun
Journal:  FEBS Lett       Date:  2020-12-09       Impact factor: 4.124

4.  ABCC5 is required for cAMP-mediated hindgut invagination in sea urchin embryos.

Authors:  Lauren E Shipp; Rose Z Hill; Gary W Moy; Tufan Gökırmak; Amro Hamdoun
Journal:  Development       Date:  2015-09-22       Impact factor: 6.868

5.  Xenobiotic transporter activity in zebrafish embryo ionocytes.

Authors:  Wei E Gordon; Jose A Espinoza; Dena M Leerberg; Deborah Yelon; Amro Hamdoun
Journal:  Aquat Toxicol       Date:  2019-04-25       Impact factor: 4.964

6.  A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.

Authors:  Tobie D Lee; Olivia W Lee; Kyle R Brimacombe; Lu Chen; Rajarshi Guha; Sabrina Lusvarghi; Bethilehem G Tebase; Carleen Klumpp-Thomas; Robert W Robey; Suresh V Ambudkar; Min Shen; Michael M Gottesman; Matthew D Hall
Journal:  Mol Pharmacol       Date:  2019-09-12       Impact factor: 4.436

7.  Global alteration of the drug-binding pocket of human P-glycoprotein (ABCB1) by substitution of fifteen conserved residues reveals a negative correlation between substrate size and transport efficiency.

Authors:  Shahrooz Vahedi; Eduardo E Chufan; Suresh V Ambudkar
Journal:  Biochem Pharmacol       Date:  2017-07-17       Impact factor: 5.858

8.  Synthesis and Characterization of Bodipy-FL-Cyclosporine A as a Substrate for Multidrug Resistance-Linked P-Glycoprotein (ABCB1).

Authors:  Andaleeb Sajid; Natarajan Raju; Sabrina Lusvarghi; Shahrooz Vahedi; Rolf E Swenson; Suresh V Ambudkar
Journal:  Drug Metab Dispos       Date:  2019-08-01       Impact factor: 3.922

9.  Novel ABCG2 Antagonists Reverse Topotecan-Mediated Chemotherapeutic Resistance in Ovarian Carcinoma Xenografts.

Authors:  Jerec W Ricci; Debbie M Lovato; Virginia Severns; Larry A Sklar; Richard S Larson
Journal:  Mol Cancer Ther       Date:  2016-09-26       Impact factor: 6.261

10.  Inhibition of glycosphingolipid biosynthesis reverts multidrug resistance by differentially modulating ABC transporters in chronic myeloid leukemias.

Authors:  Eduardo J Salustiano; Kelli M da Costa; Leonardo Freire-de-Lima; Lucia Mendonça-Previato; José O Previato
Journal:  J Biol Chem       Date:  2020-03-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.